Intra-Cellular Therapies Inc
Change company Symbol lookup
Select an option...
ITCI Intra-Cellular Therapies Inc
EAD Allspring Income Opportunities Fund
IMTE Integrated Media Technology Ltd
LIN Linde PLC
XP XP Inc
SENEA Seneca Foods Corp
LEU Centrus Energy Corp
IFF International Flavors & Fragrances Inc
$NQCAPSTN The Capital Strength Net Total Retur
XFLT XAI Octagon Floating Rate & Alternative Income Term Trust
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company provides CAPLYTA (lumateperone) for the treatment of schizophrenia in adults. The CAPLYTA is a prescription medicine used to treat the depressive episodes in adults with bipolar I or II, that can be taken alone or with lithium or valproate. The Company's pipeline is focused on three platforms: lumateperone and follow-on compounds, a phosphodiesterase 1 (PDE1) inhibitor platform and discovery platform which includes ITI-333 a novel compound with high affinity at serotonin 5-HT2A, dopamine D1 and mu opioid (MOP) receptors. The Company’s subsidiaries are ITI, Inc. (ITI) and ITI Limited.

Closing Price
$55.17
Day's Change
-1.91 (-3.35%)
Bid
--
Ask
--
B/A Size
--
Day's High
57.12
Day's Low
53.13
Volume
(Average)
Volume:
896,511

10-day average volume:
920,000
896,511

Thinking about trading options or stock in Cisco Systems, Coca-Cola, Kohl's, Target, or Coinbase?

10:55 am ET May 19, 2022 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for CSCO, KO, KSS, TGT, and COIN.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- CSCO: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=CSCO&prnumber=051920227

-- KO: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=KO&prnumber=051920227

-- KSS: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=KSS&prnumber=051920227

-- TGT: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=TGT&prnumber=051920227

-- COIN: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=COIN&prnumber=051920227

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG63548&sd=2022-05-19

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-cisco-systems-coca-cola-kohls-target-or-coinbase-301551310.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG63548&Transmission_Id=202205191055PR_NEWS_USPR_____CG63548&DateId=20220519

comtex tracking

COMTEX_407459344/1005/2022-05-19T10:55:07

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.